Vaccines biology involves the intricate interplay between the immune system and the components of vaccines designed to induce protective immunity. Vaccines leverage the biological principles of immunology to train the immune system to recognize and combat specific pathogens. Vaccine antigens, derived from viruses, bacteria, or other infectious agents, stimulate the production of antibodies and activate immune cells. Memory cells generated during vaccination provide a rapid and robust response upon subsequent exposure to the actual pathogen, conferring immunological memory. Various vaccine types exist, including live attenuated, inactivated, subunit, and mRNA vaccines, each exploiting different biological mechanisms to elicit immune responses. Live attenuated vaccines mimic natural infections, stimulating strong and long-lasting immunity, while inactivated vaccines utilize killed pathogens to trigger immune responses. Adjuvants, another essential component, enhance the immune response to vaccine antigens. They function by activating immune cells and promoting the production of cytokines, amplifying the overall effectiveness of the vaccine. Understanding the biological principles governing vaccines is pivotal for their design, development, and optimization. Ongoing research in vaccines biology continually refines our knowledge, leading to the creation of safer, more effective vaccines against a broad spectrum of infectious diseases.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia